Evidence map›Paper›PMID 37171578›Full record

ArticleDermatology and therapy2023

Treatment of Stretch Marks Using a New Formulation Combining Nanofractional Radiofrequency Plus Magnetic Nanofractional Radiofrequency.

Xiaohong Shu, Wei Huo, Lin Zou, Zhaoxia Li, Ying Tang, Li Li, Xi Wang

Open access · goldAbstract read
In one paragraph

Article in Dermatology and therapy, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.1field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Xiaohong ShuCenter of Cosmetic Evaluation, West China Hospital, Sichuan University, Chengdu, People's Republic of China.
Wei HuoCenter of Cosmetic Evaluation, West China Hospital, Sichuan University, Chengdu, People's Republic of China.
Lin ZouCenter of Cosmetic Evaluation, West China Hospital, Sichuan University, Chengdu, People's Republic of China.
Zhaoxia LiCenter of Cosmetic Evaluation, West China Hospital, Sichuan University, Chengdu, People's Republic of China.
Ying TangCenter of Cosmetic Evaluation, West China Hospital, Sichuan University, Chengdu, People's Republic of China.
Li LiCenter of Cosmetic Evaluation, West China Hospital, Sichuan University, Chengdu, People's Republic of China.
Xi WangCenter of Cosmetic Evaluation, West China Hospital, Sichuan University, Chengdu, People's Republic of China. 625412062@qq.com.ORCID http://orcid.org/0000-0001-9596-9540
Sichuan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionStretch marks are common atrophic dermal scars with significant physical and psychological effects. Therefore, there is a need for effective cosmetics and procedures for stretch mark treatment. This study aimed to evaluate the efficacy and safety of a novel treatment for stretch marks that is made up of topical formulations containing beta-glucan combined with nanofractional radiofrequency.

methodsThis randomized, blinded control trial enrolled 64 Chinese women aged 20-45 years at > 6 months after delivery with obvious white or silver abdominal stretch marks. Participants were randomly allocated to group A (blank group), group B (topical product group), group C (product combined with nanofractional radiofrequency), and group D (vehicle combined with nanofractional radiofrequency). The stretch mark width, skin elasticity, skin color, skin thickness, and collagen density were noninvasively measured. Two trained assessors evaluated the severity, color, outline, and relaxation of the striae.

resultsGroup C showed the best treatment efficacy, with no adverse effects observed during the study period.

conclusionOur findings indicate that stretch mark treatment using topical formulations containing beta-glucan, combined with nanofractional radiofrequency plus magnetic nanofractional radiofrequency, is tolerable and effective.

trial registrationChiCTR2200056725.

Indexed as

Beta-glucanNanofractional radiofrequencyStretch marks

Identifiers

PMID37171578
PMCPMC10264298
OpenAlexW4376224736

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.